SE8602917L - Furosemidsalter - Google Patents

Furosemidsalter

Info

Publication number
SE8602917L
SE8602917L SE8602917A SE8602917A SE8602917L SE 8602917 L SE8602917 L SE 8602917L SE 8602917 A SE8602917 A SE 8602917A SE 8602917 A SE8602917 A SE 8602917A SE 8602917 L SE8602917 L SE 8602917L
Authority
SE
Sweden
Prior art keywords
dosage forms
furosemide
bioavailable
affording
burden
Prior art date
Application number
SE8602917A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602917D0 (sv
Inventor
L Chafetz
J Philip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8602917D0 publication Critical patent/SE8602917D0/xx
Publication of SE8602917L publication Critical patent/SE8602917L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SE8602917A 1985-07-02 1986-07-01 Furosemidsalter SE8602917L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (2)

Publication Number Publication Date
SE8602917D0 SE8602917D0 (sv) 1986-07-01
SE8602917L true SE8602917L (sv) 1987-01-03

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602917A SE8602917L (sv) 1985-07-02 1986-07-01 Furosemidsalter

Country Status (14)

Country Link
US (1) US4663348A (enExample)
JP (1) JPS625975A (enExample)
AU (1) AU599034B2 (enExample)
BE (1) BE904986A (enExample)
CH (1) CH670448A5 (enExample)
DE (1) DE3619665A1 (enExample)
DK (1) DK312586A (enExample)
FR (1) FR2584405B1 (enExample)
GB (1) GB2189239B (enExample)
IT (1) IT1191972B (enExample)
LU (1) LU86484A1 (enExample)
NL (1) NL8601519A (enExample)
SE (1) SE8602917L (enExample)
ZA (1) ZA864207B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
DE69118716T2 (de) * 1991-12-03 1996-12-19 Kokuyo Kk Beidseitig zu öffnende/verschliessende vorrichtung zum ordnen
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2416404C1 (ru) * 2009-10-05 2011-04-20 Государственное образовательное учреждение высшего профессионального образования "Алтайский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Средство, обладающее мочегонным действием
BR112012020110B1 (pt) * 2010-02-10 2021-06-08 Kissei Pharmaceutical Co., Ltd. composto derivado heterocíclico fusionado, composição farmacêutica que compreende o mesmo e uso terapêutico do dito composto
MX367165B (es) 2013-04-05 2019-08-07 Scpharmaceuticals Inc Formulaciones farmacéuticas para administración subcutánea de furosemida.
US12403120B2 (en) 2018-12-10 2025-09-02 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
CA3123718A1 (en) 2019-01-04 2020-07-09 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
WO2020141226A1 (en) 2019-01-04 2020-07-09 Sq Innovation Ag Pharmaceutical compositions of torsemide and uses thereof
MA54865A (fr) 2019-01-31 2022-05-04 Scpharmaceuticals Inc Formulations pharmaceutiques liquides concentrées de furosémide et leurs méthodes d'administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (enExample) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
DK312586D0 (da) 1986-07-01
AU5889086A (en) 1987-01-08
NL8601519A (nl) 1987-02-02
DE3619665A1 (de) 1987-01-08
BE904986A (fr) 1986-12-24
LU86484A1 (fr) 1986-12-02
GB8615275D0 (en) 1986-07-30
JPS625975A (ja) 1987-01-12
US4663348A (en) 1987-05-05
DK312586A (da) 1987-01-03
SE8602917D0 (sv) 1986-07-01
IT8648183A0 (it) 1986-06-25
FR2584405B1 (fr) 1989-02-24
GB2189239A (en) 1987-10-21
IT1191972B (it) 1988-03-31
IT8648183A1 (it) 1987-12-25
AU599034B2 (en) 1990-07-12
FR2584405A1 (fr) 1987-01-09
CH670448A5 (enExample) 1989-06-15
ZA864207B (en) 1987-02-25
GB2189239B (en) 1989-02-01

Similar Documents

Publication Publication Date Title
SE8602917D0 (sv) Furosemidsalter
DK162986A (da) Terapeutisk middel i enhedsdosisform
SE8605515D0 (sv) A liquid dosage form for oral administration of a pharmaceutically active substance
DK642587D0 (da) Insulinpraeparat
BG85941A (bg) Лекарствена форма с контролирано освобождаване и метод за получаването й
GR76810B (enExample)
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
FI863077L (fi) Farmaceutisk dosenhet.
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
DE3482768D1 (de) Kontrastmittel und deren verwendung.
EA200200151A1 (ru) Сухая порошкообразная композиция
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
DK23386D0 (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
ES2176805T3 (es) Empleo de mezclas de productos activos para la obtencion de agentes hipocolesterinemicos.
DK515285D0 (da) Imidazoliumsalte med blodsukker-saenkende virkning og farmaceutiske midler indeholdende saadanne forbindelser
ES478272A1 (es) Un procedimiento para la preparacion de una solucion acuosa esteril y estable de cisplatina.
ES2082023T3 (es) Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
ES548988A0 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
NL188891C (nl) Farmaceutisch preparaat met bloeddrukverlagende werking dat co-dergocrine en nog een actief materiaal bevat.
IT1060117B (it) 4 alchil diossi alchilen 5 benzil pirimidine, procedimento per la loro preparazione e preparati medicinali
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DE3677181D1 (de) Wasserfreie, selektive, ionendurchlaessige elektroden zur untersuchung bestimmter ionen in waessrigen loesungen.
DK528386A (da) Proteinabsorptionsforoegende midler
IT1170342B (it) Agente farmaceutico per il trattamento di tumori in fase di metastatizzazione e di anemie da labilita' della membrana eritrocitaria

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8602917-0

Effective date: 19920201